# OnCo record hs-20093 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/hs-20093/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "hs-20093" ;
  schema:name "HS-20093"@en ;
  schema:description "HS-20093 is an experimental investigational agent whose form is not stated in the registry from Hansoh BioMedical R&D in phase 3 trials for osteosarcoma, non-small-cell lung cancer and sarcomas, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/hs-20093/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=HS-20093> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "antibody-drug conjugate (ADC), per the sponsor's pipeline page; form not stated in the registry record" ;
  onco:cancers <https://onco.cc/cancers/osteosarcoma/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/esophageal/> ;
  onco:companies <https://onco.cc/companies/hansoh-pharma/>, <https://onco.cc/companies/hengrui/> ;
  onco:trials <https://onco.cc/trials/nct06935409/>, <https://onco.cc/trials/nct06498479/>, <https://onco.cc/trials/nct05830123/>, <https://onco.cc/trials/nct07230106/>, <https://onco.cc/trials/nct06007729/>, <https://onco.cc/trials/nct06112704/> .